Ta strona używa pliki cookies, w celu polepszenia użyteczności i funkcjonalności oraz w celach statystycznych. Dowiedz się więcej w Polityce prywatności.
Korzystając ze strony wyrażasz zgodę na używanie plików cookies, zgodnie z aktualnymi ustawieniami przeglądarki.
Akceptuję wykorzystanie plików cookies
eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Share:
Share:
abstract:
Review paper

Actinic keratosis: comprehensive review of current treatments and emerging therapeutic innovations

Justyna Ceryn
1
,
Aleksandra Lesiak
1
,
Dorota Sobolewska-Sztychny
1
,
Marcin Noweta
1
,
Magdalena Ciążyńska
1
,
Joanna Narbutt
1

  1. Department of Dermatology, Paediatric Dermatology and Oncology Clinic, Medical University of Lodz, Poland
Adv Dermatol Allergol
Online publish date: 2025/01/31
View full text Get citation
 
Actinic keratosis (AK) is a prevalent benign intraepidermal dysplasia, classified as squamous cell carcinoma in situ (SCC in situ). Chronic ultraviolet (UV) light exposure is the primary etiological factor for AK, which predominantly manifests in sun-exposed areas. Management of AK emphasizes primary prevention through education, sun protection, and vigilant patient monitoring. Therapeutic strategies for AK are categorized into lesion-directed and field-directed approaches, encompassing topical treatments (imiquimod, 5-fluorouracil, diclofenac) and physical modalities (cryotherapy, photodynamic therapy, chemical peels, laser therapy, electrocoagulation, curettage). This comprehensive review discusses the current treatments and explores novel therapeutic options for AK.
keywords:

actinic keratosis, systematic review, treatment

Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.